Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Baricitinib

Product Specifications

Background

Baricitinib is a selective orally bioavailable JAK1/JAK2 inhibitor with nanomolar potency against JAK1 (IC50 = 5.9nM) and JAK2 (IC50 = 5.7nM) and inhibits Tyk2 (IC50 = 53nM) . It displays >100-fold selectivity for JAK1/2 over JAK3 (IC50 > 400nM) . Janus kinases (JAKs) are non-receptor kinases and play important roles in the proinflammatory signaling pathways that are frequently over-activated in autoimmune disorders such as rheumatoid arthritis. Upon binding of extracellular cytokines and growth factors, JAKs are phosphorylated and activate signal transducers and activators of transcription (STATs) . Via these signaling cascades, inflammatory cytokine and chemokine transcription is induced to form inflammatory mediators including IL-2, IL-6, IL-12, IL-15, IL-23. Baricitinib inhibits intracellular signaling of multiple proinflammatory cytokines including IL-6 and IL-23 at concentrations <50nM. It inhibits IL-6 receptor signaling, IL-6-induced STAT phosphorylation and subsequent pro-inflammatory chemokine (MPC-1) and cytokine (IL-17 and IL-22) production in PBMCs and T cells and displays anti-inflammatory and disease modifying effects in the rat adjuvant arthritis model. It also has been shown to block MSU-induced inflammasome activation. Baricitinib has potential application in various inflammatory disorders, including rheumatoid arthritis and systemic lupus erythematosus (SLE) . The majority of viruses enter cells through receptor mediated endocytosis. Baricitinib potently inhibits AP-2 associated protein kinase 1 (AAK1) and also binds cyclin G-associated kinase, both regulators of endocytosis. Inhibiting AAK1 might interrupt the passage of the SARS-CoV-2 virus into cells and also the intracellular assembly of virus particles. In addition the drug’s anti-inflammatory activity is expected to act on the inflammatory cascade associated with COVID-19.

CAS Number

1187594-09-7

Type

Chemical

Purity

Greater than or equal to 98% (HPLC)

Shipping Conditions

Room Temp

Storage Conditions

Short Term Storage: +4C. Long Term Storage: -20C. Handling Advice: Keep cool and dry. Use/Stability: Stable for at least 2 years after receipt when stored at -20C.

Calculated Molecular Weight

371.4

Other Product Names

LY3009104; INCB28050; 1- (Ethylsulfonyl) -3-[4- (7H-pyrrolo[2,3-d]pyrimidin-4-yl) -1H-pyrazol-1-yl]-3-azetidineacetonitrile

Physical Properties

Lyophilized

More Discoveries

Explore Other Products

Browse additional items from our catalog

Iralukast 5mg
A19429-5 5 mg

Iralukast 5mg

Sign In for Pricing
View Details
Lentiviral human TMEM131L shRNA (UAS) - Lentiviral human TMEM131L shRNA (UAS, RFP) plasmid
GTR15324244 1 Vial

Lentiviral human TMEM131L shRNA (UAS) - Lentiviral human TMEM131L shRNA (UAS, RFP) plasmid

Sign In for Pricing
View Details
C6orf62 Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
bs-9499R-BF488 100 µL

C6orf62 Polyclonal Antibody, AbBy Fluor™ 488 Conjugated

Sign In for Pricing
View Details
RTKN2 Protein Vector (Human) (pPB-C-His)
PV036505 500 ng

RTKN2 Protein Vector (Human) (pPB-C-His)

Sign In for Pricing
View Details
DNAJB2 Protein Lysate
OCOA11965-20UG 20 µg

DNAJB2 Protein Lysate

Sign In for Pricing
View Details
5-Bromo-4-fluoro-2-methoxybenzonitrile
PC1001280-01 100 mg

5-Bromo-4-fluoro-2-methoxybenzonitrile

Sign In for Pricing
View Details